ELUT FY 2024 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$24M-1.5% YoY

Gross Profit

$11M43.9% margin

Operating Income

-$36M-146.3% margin

Net Income

-$54M-221.3% margin

EPS (Diluted)

$-1.86

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$36M

Total Liabilities

$82M

Stockholders' Equity

-$46M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$25M	-1.5%
Gross Profit	$11M	$11M	-3.1%
Operating Income	-$36M	-$31M	-16.8%
Net Income	-$54M	-$38M	-43.3%